J Korean Neurol Assoc.
2016 Feb;34(1):77-79. 10.17340/jkna.2016.1.17.
Reduction of Disease Activity in Patient with Relapsing-Remitting Multiple Sclerosis after Switching to Teriflunomide from Interferon Beta
- Affiliations
-
- 1Department of Neurology, Yeungnam University College of Medicine, Daegu, Korea. minsupark@ynu.ac.kr
- KMID: 2153170
- DOI: http://doi.org/10.17340/jkna.2016.1.17
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- A case of childhood relapsing/remitting multiple sclerosis and interferon beta-1b treatment in a Korean patient
- Two Cases of Primary Sjogren's Syndrome Presenting as Relapsing-Remitting Multiple Sclerosis
- Chronic Inflammatory Demyelinating Polyneuropathy Developed during Interferon-beta Therapy in a Patient with Multiple Sclerosis
- Changes in the Multiple Sclerosis Treatment Paradigm. What Do We Do Now and What Were We Doing Before?
- Interferon-beta Induced Skin Necrosis
